Senior member of CDPQ’s Infrastructure Financing mandate (~$10B AUM) that provides senior and junior private debt solutions to infrastructure assets globally and across a variety of essential sectors (low carbon energy, telecom, transportation, water utilities, etc.) Managed the complete transaction cycle: origination, structuration, negotiation, due diligence, coordination of multi-disciplinary teams, complex legal contracts negotiation, internal investment approval process, post-investment monitoring and risk management. Successfully deployed $600M+ per year with an average per transaction investment size of $200M+, typically as the sole or the anchor lender in directly negotiated bespoke transactions. Illustrative transactions include:Sole lender in a £150M junior facility to Lightsource BP (a solar IPP) to finance equity contribution into newly developed solar projects, €200M+ anchor commitment to a Catalonian P3 senior debt refinancing, £200M+ mezzanine financing to a UK water utility, €200M+ combined senior and junior financing to support the build out of a fiber network in Europe, US$200M anchor commitment to Fundamental Renewables, a specialty lender active in the US solar energy sector.Managed the Infrastructure Financing mandate’s Québec-based relationships (e.g. Boralex, Power Sustainables, Axium, SNC-Lavalin, Aéroport de Montréal, etc) representing >$1.5B+ in loan commitments as well as supporting the broader CDPQ positioning initiatives in the energy transition sector.

Responsible for managing the relationship with 25+ of the bank’s largest corporate clients representing ongoing credit exposure totalling ~$4.5B, ensuring optimally efficient utilization of the bank’s capital and compliance with the bank’s lending and risk management guidelines. Actively managed credit exposure from deal sourcing, structuring, due diligence, internal approval process (including presentations to the global risk management committee/board), legal documentation, syndication to ongoing monitoring. Managed credit exposure in a variety of financing initiatives: revolving / term credit facilities (syndicated or bilateral, secured or unsecured), M&A related bridge financings, project / P3 financings, shareholder / holdco financings, letters of credit facilities, subordinated financings, factoring facilities, derivatives facilities etc. Coordinated ~15 syndicated credit facilities as pivotal role of lead/co-lead arranger, earning highly valued league table contribution to the benefit of the bank market presence, and served as co-team leader of NBF for Québec’s Consumer & Retail industry, maximized cross-sell opportunities for the bank platform (derivatives, investment banking, equity/debt capital markets). Structured multiple fully committed acquisition financings supporting some of Canada's major M&A transactions. Led and managed NBC’s direct preferred shares investments in the capital of Agropur and La Coop fédérée.

Leadership role from a corporate viewpoint, leading and coordinating Domtar’s M&A projects. Advised the Management Committee in its evaluation of potential growth opportunities and executed Domtar’s acquisition projects, functioning as team leader on the acquisitions of US-based EAM Corporation (US$61M) from Kinderhook Capital Partners and of UK-based Attends Healthcare (€180M) from Rutland Partners.

Actively involved in advising public and private companies and institutional / private equity investors with respect to acquisitions, divestitures, restructurings and capital markets financings. These activities included (among many others) the following illustrative transactions: i) Lead arranger on Dollarama’s highly successful $345M IPO which was named as Canadian Dealmakers’ 2009 IPO of the Year. Worked in close collaboration with Bain Capital who held a majority share in Dollarama; the IPO process was substantially over-subscribed and amongst the shortest ever from kick-off in August to closing in early October ii) Co-advisor to Noverco on a $600M reorganization of Gaz Métro and the creation of Valener, a new investment vehicle held by the former minority shareholders of Gaz Métro iii) Lead arranger on SNC-Lavalin’s $350M offering of public debentures iv) Advisor to the special committee of the board of Spectra Premium on its $127M buy-out by its management and FSTQ v) Lead arranger on RONA's $300M IPO of public debentures vi) Lead arranger on Atrium Innovations' $75M equity IPO.

For the first two years with Merrill Lynch based in its Montreal office, I carried out financial modeling, prepared pitch books and provided other support for deals’ origination and execution, and was then promoted to Associate in the European Chemicals and Healthcare team based in London, UK. In this position, I was actively involved in advising companies and private equity investors with respect to M&A and financing transactions; examples of my involvement are the divestiture of German-based Henkel on its €2.5B sale of its specialty chemicals business and the €2.25B sale of Swiss-based Roche of its vitamins business to Dutch-based DSM.